csirt@kutim:~/threat-intel/cve/CVE-2026-82755

Katalog CVE

CVSS 6.3 · Medium EPSS 0,66%

Kerentanan Use of Cache Containing Sensitive Information. Skor CVSS 4.0 6.3 (Medium) menurut CNA.

Deskripsi (NVD)

Use of Cache Containing Sensitive Information vulnerability in ash-project ash_authentication_oauth2_server allows a shared HTTP cache to serve one tenant's OAuth discovery metadata to another tenant's clients. The RFC 8414 and RFC 9728 metadata endpoints in AshAuthentication.Phoenix.Oauth2Server.ProtocolRouter return tenant-specific values (issuer, authorization_endpoint, token_endpoint, jwks_uri) when a tenant is set, but sent them with Cache-Control: public, max-age=3600 and no Vary. When the tenant is derived from something other than the URL (a header or the Host) and a shared cache sits in front, the cache key is the URL alone, so a stored response for one tenant is served to another for up to an hour. Affected clients may then send authorization codes and secrets to the wrong tenant's token endpoint and validate tokens against the wrong keys. This issue affects ash_authentication_oauth2_server: from 0.1.3 before 0.3.1.

Rincian

Terbit di NVD
7 September 2026
Terakhir diubah
8 September 2026
Status NVD
Deferred
CVSS 4.0
6.3 (Medium), sumber CNA
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-524: Use of Cache Containing Sensitive Information
EPSS (30 hari)
0,66% peluang dieksploitasi; lebih tinggi dari 50,1% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.